{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,5]],"date-time":"2026-11-05T09:05:48Z","timestamp":1793869548257,"version":"4.6.1"},"reference-count":25,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T00:00:00Z","timestamp":1669852800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T00:00:00Z","timestamp":1669852800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,9,9]],"date-time":"2022-09-09T00:00:00Z","timestamp":1662681600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Urology"],"published-print":{"date-parts":[[2022,12]]},"DOI":"10.1016\/j.eururo.2022.09.008","type":"journal-article","created":{"date-parts":[[2022,10,6]],"date-time":"2022-10-06T22:58:16Z","timestamp":1665097096000},"page":"646-656","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":79,"title":["Elevated T-cell Exhaustion and Urinary Tumor DNA Levels Are Associated with Bacillus Calmette-Gu\u00e9rin Failure in Patients with Non\u2013muscle-invasive Bladder Cancer"],"prefix":"10.1016","volume":"82","author":[{"given":"Trine","family":"Strandgaard","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sia Viborg","family":"Lindskrog","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Iver","family":"Nordentoft","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emil","family":"Christensen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karin","family":"Birkenkamp-Demtr\u00f6der","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tine Ginnerup","family":"Andreasen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Philippe","family":"Lamy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Asbj\u00f8rn","family":"Kj\u00e6r","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel","family":"Ranti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuanshuo Alice","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christine","family":"Bieber","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Frederik","family":"Prip","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julie","family":"Rasmussen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Torben","family":"Steiniche","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicolai","family":"Birkbak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John","family":"Sfakianos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amir","family":"Horowitz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J\u00f8rgen Bjerggaard","family":"Jensen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lars","family":"Dyrskj\u00f8t","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.eururo.2022.09.008_b0005","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1016\/j.eururo.2019.08.016","article-title":"European Association of Urology guidelines on non\u2013muscle-invasive bladder cancer (TaT1 and carcinoma in situ)\u20142019 update","volume":"76","author":"Babjuk","year":"2019","journal-title":"Eur Urol"},{"key":"10.1016\/j.eururo.2022.09.008_b0010","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1016\/j.eururo.2015.06.045","article-title":"EORTC nomograms and risk groups for predicting recurrence, progression, and disease-specific and overall survival in non\u2013muscle-invasive stage Ta\u2013T1 urothelial bladder cancer patients treated with 1\u20133 years of maintenance bacillus Calmette-Gu\u00e9rin","volume":"69","author":"Cambier","year":"2016","journal-title":"Eur Urol"},{"key":"10.1016\/j.eururo.2022.09.008_b0015","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1038\/s41585-021-00481-1","article-title":"100 years of bacillus Calmette-Gu\u00e9rin immunotherapy: from cattle to COVID-19","volume":"18","author":"Lobo","year":"2021","journal-title":"Nat Rev Urol"},{"key":"10.1016\/j.eururo.2022.09.008_b0020","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1038\/s41585-018-0055-4","article-title":"Mechanisms of BCG immunotherapy and its outlook for bladder cancer","volume":"15","author":"Pettenati","year":"2018","journal-title":"Nat Rev Urol"},{"key":"10.1016\/j.eururo.2022.09.008_b0025","doi-asserted-by":"crossref","first-page":"1030","DOI":"10.1038\/s41590-021-00982-6","article-title":"Differentiation of exhausted CD8 T cells after termination of chronic antigen stimulation stops short of achieving functional T cell memory","volume":"22","author":"Tonnerre","year":"2021","journal-title":"Nat Immunol"},{"key":"10.1016\/j.eururo.2022.09.008_b0030","doi-asserted-by":"crossref","first-page":"622509","DOI":"10.3389\/fimmu.2020.622509","article-title":"Exhausted CD8+T cells in the tumor immune microenvironment: new pathways to therapy","volume":"11","author":"Jiang","year":"2020","journal-title":"Front Immunol"},{"key":"10.1016\/j.eururo.2022.09.008_b0035","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1080\/14728222.2021.1937123","article-title":"Reversing T-cell exhaustion in immunotherapy: a review on current approaches and limitations","volume":"25","author":"Tabana","year":"2021","journal-title":"Expert Opin Ther Targets"},{"key":"10.1016\/j.eururo.2022.09.008_b0040","doi-asserted-by":"crossref","first-page":"899","DOI":"10.1038\/s41573-021-00155-y","article-title":"Beyond immune checkpoint blockade: emerging immunological strategies","volume":"20","author":"Kubli","year":"2021","journal-title":"Nat Rev Drug Discov"},{"key":"10.1016\/j.eururo.2022.09.008_b0045","doi-asserted-by":"crossref","first-page":"919","DOI":"10.1016\/S1470-2045(21)00147-9","article-title":"Pembrolizumab monotherapy for the treatment of high-risk non-muscle-invasive bladder cancer unresponsive to BCG (KEYNOTE-057): an open-label, single-arm, multicentre, phase 2 study","volume":"22","author":"Balar","year":"2021","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.eururo.2022.09.008_b0050","doi-asserted-by":"crossref","first-page":"882","DOI":"10.1158\/1078-0432.CCR-19-1920","article-title":"Adaptive immune resistance to intravesical BCG in non\u2013muscle invasive bladder cancer: implications for prospective BCG-unresponsive trials","volume":"26","author":"Kates","year":"2020","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.eururo.2022.09.008_b0055","doi-asserted-by":"crossref","first-page":"2301","DOI":"10.1038\/s41467-021-22465-w","article-title":"An integrated multi-omics analysis identifies prognostic molecular subtypes of non-muscle-invasive bladder cancer","volume":"12","author":"Lindskrog","year":"2021","journal-title":"Nat Commun"},{"key":"10.1016\/j.eururo.2022.09.008_b0060","doi-asserted-by":"crossref","first-page":"eaaf8399","DOI":"10.1126\/science.aaf8399","article-title":"Tumor aneuploidy correlates with markers of immune evasion and with reduced response to immunotherapy","volume":"355","author":"Davoli","year":"2017","journal-title":"Science"},{"key":"10.1016\/j.eururo.2022.09.008_b0065","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1186\/s40425-017-0215-8","article-title":"Gene expression markers of tumor infiltrating leukocytes","volume":"5","author":"Danaher","year":"2017","journal-title":"J Immunother Cancer"},{"key":"10.1016\/j.eururo.2022.09.008_b0070","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1038\/s42003-020-1097-8","article-title":"CD70 expression determines the therapeutic efficacy of expanded human regulatory T cells","volume":"3","author":"Arroyo Hornero","year":"2020","journal-title":"Commun Biol"},{"key":"10.1016\/j.eururo.2022.09.008_b0075","doi-asserted-by":"crossref","first-page":"3700","DOI":"10.4049\/jimmunol.1700380","article-title":"T cell-derived CD70 delivers an immune checkpoint function in inflammatory T cell responses","volume":"199","author":"O\u2019Neill","year":"2017","journal-title":"J Immunol"},{"key":"10.1016\/j.eururo.2022.09.008_b0080","doi-asserted-by":"crossref","first-page":"5352","DOI":"10.4049\/jimmunol.0802809","article-title":"Protective CD8 T cell memory is impaired during chronic CD70-driven costimulation","volume":"182","author":"van Gisbergen","year":"2009","journal-title":"J Immunol"},{"key":"10.1016\/j.eururo.2022.09.008_b0085","doi-asserted-by":"crossref","first-page":"1463","DOI":"10.1126\/science.aaf1490","article-title":"Clonal neoantigens elicit T cell immunoreactivity and sensitivity to immune checkpoint blockade","volume":"351","author":"McGranahan","year":"2016","journal-title":"Science"},{"key":"10.1016\/j.eururo.2022.09.008_b0090","doi-asserted-by":"crossref","unstructured":"de Jong FC, Laajala TD, Hoedemaeker RF, et al. Non-muscle invasive bladder cancer molecular subtypes predict differential response to intravesical bacillus Calmette-Gu\u00e9rin. medRxiv preprint. https:\/\/doi.org\/10.1101\/2021.11.30.21266988","DOI":"10.1101\/2021.11.30.21266988"},{"key":"10.1016\/j.eururo.2022.09.008_b0095","doi-asserted-by":"crossref","first-page":"9043","DOI":"10.18632\/aging.202756","article-title":"Mucin 4 mutation is associated with tumor mutation burden and promotes antitumor immunity in colon cancer patients","volume":"13","author":"Peng","year":"2021","journal-title":"Aging"},{"key":"10.1016\/j.eururo.2022.09.008_b0100","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1158\/2326-6066.CIR-15-0274","article-title":"Molecular drivers of the non-T-cell-inflamed tumor microenvironment in urothelial bladder cancer","volume":"4","author":"Sweis","year":"2016","journal-title":"Cancer Immunol Res"},{"key":"10.1016\/j.eururo.2022.09.008_b0105","doi-asserted-by":"crossref","first-page":"4599","DOI":"10.1158\/1078-0432.CCR-21-0205","article-title":"Identification of a novel inflamed tumor microenvironment signature as a predictive biomarker of bacillus Calmette-Gu\u00e9rin immunotherapy in non-muscle-invasive bladder cancer","volume":"27","author":"Damrauer","year":"2021","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.eururo.2022.09.008_b0110","doi-asserted-by":"crossref","first-page":"61","DOI":"10.21037\/tau.2018.11.05","article-title":"The current role of circulating biomarkers in non-muscle invasive bladder cancer","volume":"8","author":"Rink","year":"2019","journal-title":"Transl Androl Urol"},{"key":"10.1016\/j.eururo.2022.09.008_b0115","unstructured":"Pfizer. A study of sasanlimab in people with non-muscle invasive bladder cancer (CREST). https:\/\/clinicaltrials.gov\/ct2\/show\/NCT04165317."},{"key":"10.1016\/j.eururo.2022.09.008_b0120","unstructured":"ImmunityBio, Inc. QUILT-3.032: a multicenter clinical trial of intravesical bacillus Calmette-Guerin (BCG) in combination with ALT-803 (N-803) in patients with BCG unresponsive high grade non-muscle invasive bladder cancer. https:\/\/clinicaltrials.gov\/ct2\/show\/NCT03022825."},{"key":"10.1016\/j.eururo.2022.09.008_b0125","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1016\/j.eururo.2020.12.033","article-title":"European Association of Urology (EAU) prognostic factor risk groups for non\u2013muscle-invasive bladder cancer (NMIBC) incorporating the WHO 2004\/2016 and WHO 1973 classification systems for grade: an update from the EAU NMIBC Guidelines Panel","volume":"79","author":"Sylvester","year":"2021","journal-title":"Eur Urol"}],"container-title":["European Urology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0302283822026367?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0302283822026367?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,4]],"date-time":"2025-10-04T13:12:19Z","timestamp":1759583539000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0302283822026367"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,12]]},"references-count":25,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2022,12]]}},"alternative-id":["S0302283822026367"],"URL":"https:\/\/doi.org\/10.1016\/j.eururo.2022.09.008","relation":{"has-preprint":[{"id-type":"doi","id":"10.1101\/2022.03.23.22272806","asserted-by":"object"}]},"ISSN":["0302-2838"],"issn-type":[{"value":"0302-2838","type":"print"}],"subject":[],"published":{"date-parts":[[2022,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Elevated T-cell Exhaustion and Urinary Tumor DNA Levels Are Associated with Bacillus Calmette-Gu\u00e9rin Failure in Patients with Non\u2013muscle-invasive Bladder Cancer","name":"articletitle","label":"Article Title"},{"value":"European Urology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.eururo.2022.09.008","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 The Author(s). Published by Elsevier B.V. on behalf of European Association of Urology.","name":"copyright","label":"Copyright"}]}}